Clinical Trial Update: An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and Flu [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Theraflu Night Powder as an oral solution for cold and flu has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• Theraflu Night Powder (oral solution)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Respiratory Tract | Phase 3 | Status: WITHDRAWN